Antibacterial activity of bovine lactoferrin and its peptides against enterohaemorrhagic Escherichia coli O157:H7

Letters in Applied Microbiology

Volumn 26, Issue 6, 1998, Pages 407-411

  Shin, K ^a   Yamauchi, K ^a   Teraguchi, S ^a   Hayasawa, H ^a   Tomita, M ^a   Otsuka, Y ^b   Yamazaki, S ^b  

^a MORINAGA MILK INDUSTRY CO LTD   (Japan)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ESCHERICHIA COLI; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MAMMALS;

ACTIVE PEPTIDES; ANTI-BACTERIAL ACTIVITY; ANTI-MICROBIAL ACTIVITY; BOVINE LACTOFERRIN; CLINICAL ISOLATES; E.COLI O157:H7; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI O157:H7; LACTOFERRICIN; PEPSIN HYDROLYSATES;

PEPTIDES;

LACTOFERRIN; PEPTIDE; PROTEIN HYDROLYSATE; VEROTOXIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOPLASM; ESCHERICHIA COLI O157; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; TRANSMISSION ELECTRON MICROSCOPY;

BACTERIA (MICROORGANISMS); BOVINAE; ESCHERICHIA COLI; NEGIBACTERIA;

EID: 0031869799     PISSN: 02668254     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1472-765X.1998.00358.x     Document Type: Article

References (16)

1. Arnold, R.R., Brewer, M. and Gauthier, J.J. (1980) Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Injection and Immunity 28, 893-898.
2. Bellamy, W., Takase, M., Wakabayashi, H., Kawase, K. and Tomita, M. (1992a) Antibacterial spectrum of lactoferricin B, a potent bacterial peptide derived from the N-terminal region of bovine lactoferrin. Journal of Applied Bacteriology 73, 472-179.
3. Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K. and Tomita, M. (1992b) Identification of the bactericidal domain of lactoferrin. Biochimica et Biophysica Acta 1121, 130-136.
4. Bellamy, W., Wakabayashi, H., Takase, M., Kawase, K., Shimamura, S. and Tomita, M. (1993) Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin. Medical Microbiology and Immunology 182, 97-105.
5. Bitzan, M., Müller-Wiefel, D.E., Schwarzkopf, A. and Karch, H. (1992) Zur Rolle von Antibiotika beim Management des Verotoxin-assoziierten hämolytish-urämischen Syndroms. Immunitat und Infektion 20, 168-172.
6. Bullen, J.J., Rogers, H.J. and Leigh, L. (1992) Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. British Medical Journal 1, 69-75.
7. Cimolai, N., Carter, J.K., Morrison, B.J. and Anderson, J.D. (1990) Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. Journal of Pediatrics 116, 589-592.
8. Law, B.A. and Reiter, B. (1977) The isolation and bacteriostatic properties of lactoferrin from bovine milk whey. Journal of Dairy Research 44, 595-599.
9. Masson, P.L., Heremans, J.F. and Dive, C. (1966) An iron-binding protein common to many external secretions. Clinica Chimica Acta 14, 735-739.
10. Miyauchi, J. and Watanabe, Y. (1987) Immunocytochemical localization of lactoferrin in human neutrophils. An ultrastructural and morphometrical study. Cell and Tissue Research 247, 249-258.
11. Scotland, S.M., Smith, H.R. and Rowe, B. (1985) Two distinct toxins active on Vero cells from Escherichia coli 157. Lancet 2, 885-886.
12. Takeda, Y. (1997) Enterohaemorrhagic Escherichia coli. World Health Statistics Quarterly 50, 74-80.
13. Tomita, M., Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H. and Kawase, K. (1991) Potent antimicrobial peptides generated by pepsin digestion of bovine lactoferrin. Journal of Dairy Science 74, 4137-4142.
14. Valenti, P., Visca, P., Antonini, G. and Orsi, N. (1986) Interaction between lactoferrin and ovotransferrin and Candida cells. FEMS Microbiology Letters 33, 271-275.
15. Walterspiel, J.N., Ashkenazi, S., Morrow, A.L. and Cleary, T.G. (1992) Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I. Infection 20, 25-29.
16. Yamauchi, K., Tomita, M., Giehl, T.J. and Ellison, III, R.T. (1993) Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infection and Immunity 61, 719-728.